GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R208. A total of 15 filers reported holding GENETIC TECHNOLOGIES LTD in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $12,000 | – | 11,875 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 1,070,333 | $1,156,000 | 0.07% |
TWO SIGMA SECURITIES, LLC | 49,007 | $53,000 | 0.02% |
ARXIS SECURITIES LLC | 11,875 | $12,000 | 0.02% |
Renaissance Technologies | 679,080 | $733,000 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 923,358 | $997,000 | 0.00% |
UBS Group AG | 1,000 | $1,000 | 0.00% |
CITIGROUP INC | 300 | $0 | 0.00% |
PRELUDE CAPITAL MANAGEMENT, LLC | 100 | $0 | 0.00% |
Financial Architects, Inc | 350 | $0 | 0.00% |
SIMPLEX TRADING, LLC | 956 | $1,000 | 0.00% |